دوره 4، شماره 3 و 4 - ( 8-1396 )                   جلد 4 شماره 3 و 4 صفحات 63-55 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghareeb D, Shaban N, Habashy N, El-Demella M, El-Rashidy F. Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells. vacres 2017; 4 (3 and 4) :55-63
URL: http://vacres.pasteur.ac.ir/article-1-113-fa.html
Constructions of hepatitis C Virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells. Vaccine Research. 1396; 4 (3 و 4) :55-63

URL: http://vacres.pasteur.ac.ir/article-1-113-fa.html


چکیده:   (6096 مشاهده)
Introduction: Dendritic cells (DCs) have been recently employed as carriers for vaccines against several viral infections. The present study was designed to develop a prophylactic vaccine against hepatitis C virus (HCV) using DCs treated with Berberis vulgaris root extract (BRE), as a preclinical study. Methods: BRE was prepared and injected to female BALB/c mice for DCs expansion. The expanded splenocyte cells (EDC) were purified and efficiently loaded ex vivo with HCV-nonstructural protein 3, NS3, (EDC-NS3). Mice were subcutaneously inoculated with EDC-NS3 vaccine candidate thrice with 4-week-intervals and IL-12, IFN-γ, IL-4, IL-10, MHC class II, CD3, CD16, indoleamine 2, 3 dioxygenase (IDO) and total protein levels were measured, post-vaccination by PCR and flow cytometry. Moreover, cytotoxic T lymphocyte and humoral immune responses were examined. Results: Our data revealed that immunization with EDC-NS3 vaccine elevated IL-12, IFN-γ and IL-4 expressions as well as MHC II and CD16 at protein levels. It also elicited strong HCV-NS3-specific humoral and cellular immune responses. However, the expressions of CD3, IDO, and IL-10 were down-regulated, post-vaccination. Conclusion: EDC-NS3 immunization serves as an innovative modality for immunoprophylaxis against HCV infection.
متن کامل [PDF 1050 kb]   (1725 دریافت)    
نوع مطالعه: Original article |
دریافت: 1397/3/30

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Vaccine Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.